These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 31895402)

  • 1. How Is Money Changing Medicine?-Venture Capital Investment in Oncology.
    Huang KB; Nambudiri VE
    JAMA Oncol; 2020 Mar; 6(3):325-326. PubMed ID: 31895402
    [No Abstract]   [Full Text] [Related]  

  • 2. Cancer clinical research: return on investment in the era of value-based purchasing.
    Holcombe RF
    J Oncol Pract; 2014 Sep; 10(5):327-8. PubMed ID: 24939181
    [No Abstract]   [Full Text] [Related]  

  • 3. Interactions with the investment industry: practical and ethical implications.
    American Society of Clinical Oncology
    J Clin Oncol; 2007 Jan; 25(3):338-40. PubMed ID: 17235050
    [No Abstract]   [Full Text] [Related]  

  • 4. Information Sharing and Investment Performance in the Venture Capital Network Community: An Empirical Study of Environmental-Social-Governance Start-Ups.
    Xue C; Dang X; Shi B; Gu J
    Int J Environ Res Public Health; 2019 Mar; 16(6):. PubMed ID: 30897837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost of cancer care: issues and implications.
    Meropol NJ; Schulman KA
    J Clin Oncol; 2007 Jan; 25(2):180-6. PubMed ID: 17210937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoting medical innovation while developing sound social and business policy: a conversation with Thomas G. Roberts. Interview by Barbara J. Culliton.
    Roberts TG
    Health Aff (Millwood); 2008; 27(1):w34-40. PubMed ID: 18042561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Healthcare venture capital for Africa.
    Chakma J; Sammut SM
    Science; 2011 Feb; 331(6017):532-3; author reply 533-4. PubMed ID: 21292953
    [No Abstract]   [Full Text] [Related]  

  • 8. Physician entrepreneur: lessons learned in raising capital for biomedical innovation.
    Soleimani F; Kharabi DG
    Curr Opin Anaesthesiol; 2010 Apr; 23(2):209-17. PubMed ID: 20173634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venture Capital in US Medicine: A Briefing for Radiologists.
    Lexa FJ; Van Moore A
    J Am Coll Radiol; 2024 Mar; 21(3):489-492. PubMed ID: 37813222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venture Capital Investment in the Life Sciences in Switzerland.
    Hosang M
    Chimia (Aarau); 2014 Dec; 68(12):847-9. PubMed ID: 26508600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venture Capital Investments for Life Sciences Start-ups in Switzerland.
    Gantenbein P; Herold N
    Chimia (Aarau); 2014 Dec; 68(12):836-9. PubMed ID: 26508597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Confidence in 'selecting the winners'.
    Barkholz D
    Mod Healthc; 2017 Apr; 47(15):31. PubMed ID: 30423229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A money-making 'venture'. Healthcare executives need to spend time on research and development via venture capital.
    Cain D
    Mod Healthc; 1999 Nov; 29(45):72. PubMed ID: 10623268
    [No Abstract]   [Full Text] [Related]  

  • 14. When reimbursement issues go beyond reimbursement.
    Abraham BC
    J Oncol Manag; 2002; 11(6):31-2. PubMed ID: 12502291
    [No Abstract]   [Full Text] [Related]  

  • 15. The decline of venture capital investment in early-stage life sciences poses a challenge to continued innovation.
    Fleming JJ
    Health Aff (Millwood); 2015 Feb; 34(2):271-6. PubMed ID: 25646107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Industry, clinical trials, and the cost of cancer drugs: an investor's perspective.
    Fiorino T
    J Clin Oncol; 2007 Jul; 25(19):e21-3. PubMed ID: 17602065
    [No Abstract]   [Full Text] [Related]  

  • 17. Venturing outside. Providers try outsourcing to bolster cancer-care programs as new technologies, reimbursement pressures add to challenges.
    Zigmond J
    Mod Healthc; 2007 Oct; 37(42):26-8. PubMed ID: 18020049
    [No Abstract]   [Full Text] [Related]  

  • 18. The continuing evolution of technology in cancer care.
    Kulkarni K
    Future Oncol; 2016 Sep; 12(17):1961-5. PubMed ID: 27150847
    [No Abstract]   [Full Text] [Related]  

  • 19. CRUK Invests £15 Million in Research Hubs.
    Cancer Discov; 2015 Sep; 5(9):897-8. PubMed ID: 26201899
    [No Abstract]   [Full Text] [Related]  

  • 20. How venture capital works.
    Zider B
    Harv Bus Rev; 1998; 76(6):131-9. PubMed ID: 10187243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.